AbbVie (ABBV)
(Real Time Quote from BATS)
$170.06 USD
+2.17 (1.29%)
Updated Apr 23, 2024 11:02 AM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 21% (199 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.89 | 2.10 | 9.99 |
Current Quarter Estimate | 2.26 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 2.46 | 11.39 | 52.54 |
Next Quarter Estimate | 2.79 | 34.85 | 61.00 |
Next Year Estimate | 12.16 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 0.09 | 3.70 | 17.08 |
Next Year | 9.35 | 16.00 | 8.00 |
Last 5 Years | 8.20 | 3.00 | 8.10 |
Next 5 Years | 7.00 | 11.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.11 | 15.53 |
Price/Book (MRQ) | 29.07 | 5.30 |
Price/Cash Flow (MRFY) | 10.62 | 10.16 |
Dividend Yield | 3.69% | 2.85% |
Net Profit Margin (TTM) | 8.95% | 45.26% |
Return on Equity (TTM) | 162.28% | 36.43% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.